Ozaraga, Justina A.
HRN: 10-83-00 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/11/2023
CEFTRIAXONE 1G (VIAL)
08/11/2023
08/17/2023
IV
2gm
Q24
Cap Mr
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes